Astaxanthin Lowers Inflammation

Astaxanthin Lowers Inflammation

KAILUA KONA, HawaiiAstaxanthin inhibits inflammation, according toresults of a preliminary study supported by Cyanotech Corp. (www.cyanotech.com).

In the double blind study, scientists from an independent research groupadministered astaxanthin (as BioAstin®, from Cyanotech; n=15) or placebo (n=8)for 56 days. Supplementation with astaxanthin reduced systemic inflammation (as measuredby levels of C-Reactive Protein [CRP] in blood serum) by more than 20 percent.Administration of placebo did not reduce CRP levels; there was a statisticallysignificant difference between the two treatment conditions, suggesting BioAstinmay significantly reduce CRP scores.

While highly encouraging, this finding was based on a small sample sizeand, ideally, should be replicated in a larger study, said Gerald R.Cysewski,Ph.D., chairman, president and chief executive officer (CEO) of Cyanotech. Consideringrecent literature on the importance of CRP as an indicator of cardiac health,the finding of such a substantial average reduction in CRP after a regimen ofBioAstin is a promising result that deserves further attention.This study addsto the body of research being developed that supports the anti-inflammatoryproperties of BioAstin Natural Astaxanthin. Previous studies have shown thebenefit of using BioAstin for varied inflammation-related conditions, includingrheumatoid arthritis, carpal tunnel syndrome, joint soreness and sunburn.